| Long-term adopters |  | Short-term adopters |  | Non-adopters |  | P-value |
---|---|---|---|---|---|---|---|
 | N | % | N | % | N | % |  |
Total | 327 | 100 | 48 | 100 | 205 | 100 | Â |
   Accreditation level |  |  |  |  |  |  |  |
   Medical Center | 18 | 5 | 0 | 0 | 1 | 0 |  |
   Regional Hospital | 68 | 21 | 2 | 4 | 8 | 4 |  |
   District Hospital | 241 | 74 | 46 | 96 | 196 | 96 | 0.00004 |
Ownership | Â | Â | Â | Â | Â | Â | Â |
   Public Hospital | 67 | 20 | 7 | 15 | 17 | 8 |  |
   Non-profit Hospital | 65 | 20 | 3 | 6 | 4 | 2 |  |
   Private Hospital | 195 | 60 | 38 | 79 | 184 | 90 | 0.00004 |
BNHI Regions | Â | Â | Â | Â | Â | Â | Â |
   Taipei | 78 | 24 | 12 | 25 | 26 | 13 |  |
   Northern | 49 | 15 | 6 | 12 | 23 | 11 |  |
   Central | 81 | 25 | 5 | 10 | 40 | 20 |  |
   Southern | 49 | 15 | 9 | 19 | 40 | 20 |  |
   Kao-Ping | 59 | 18 | 14 | 29 | 72 | 35 |  |
   Eastern | 11 | 3 | 2 | 5 | 4 | 1 | 0.00034 |
 | mean | Std | mean | Std | mean | Std |  |
Herfindahl-Hirschman Indexes1 (HHI) | 0.339 | 0.137 | 0.45 | 0.180 | 0.57 | 0.223 | 0.00005 |
Number of doctors who prescribed TZD drug | 34.02 | 66.97 | 4.86 | 5.16 | - | - | Â |
Initial TZD use after TA (month) | 15.19 | 11.61 | 36.79 | 16.00 | - | - | Â |
Total DDD of DM2 (DDD) | 37917.47 | 77383.05 | 8468 | 12601 | 2243 | 3958 | 0.00005 |
 | mean | Std |  |  |  |  |  |
Maximum monthly TZD penetration3 | 0.117 | 0.067 | - | - | - | - | Â |
Time between initial adoption and the maximum penetration (month) | 26.14 | 13.16 | - | - | - | - | Â |
 | mean | Std |  |  |  |  |  |
Peak use (maximum monthly prescription of TZD in DDD) | 6970.01 | 12678.72 | - | - | - | - | Â |
The time between initial adoption to the maximum prescription of TZD (month) | 27.02 | 13.17 | - | - | - | - | Â |
Prescription Speed (monthly growth on TZD prescription in DDD) | 252.65 | 374.31 | - | - | - | - | Â |
Maximum prescription in DDD | Â | Â | Â | Â | Â | Â | Â |
25% quantile | Â | 924.83 | - | - | - | - | Â |
50% quantile | Â | 2488 | - | - | - | - | Â |
75% quantile | Â | 6454.83 | - | - | - | - | Â |
Rate of penetration | Â | Â | Â | Â | Â | Â | Â |
25% quantile | Â | 39.99 | - | - | - | - | Â |
50% quantile | Â | 111.22 | - | - | - | - | Â |
75% quantile | Â | 293.97 | - | - | - | - | Â |